HPV and HPV Vaccination Knowledge and Attitudes Among Medical Students in Alabama.
HPV
Human papillomavirus
Medical education
Student
Vaccination
Journal
Journal of cancer education : the official journal of the American Association for Cancer Education
ISSN: 1543-0154
Titre abrégé: J Cancer Educ
Pays: England
ID NLM: 8610343
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
pubmed:
11
9
2019
medline:
24
8
2021
entrez:
11
9
2019
Statut:
ppublish
Résumé
In addition to being the most common sexually transmitted infection, the human papillomavirus (HPV) is associated with six types of cancer in men and women. The HPV vaccine provides long-lasting, effective protection from high-risk HPV infection, thus serving as a means of cancer prevention. An effective healthcare provider recommendation is well-established as the most significant influence on HPV vaccine uptake, and, as emerging providers, it is critical that medical students receive comprehensive training in this area. However, the type and extent of such training for current medical students in the USA is unclear. An online survey assessing HPV and HPV vaccine knowledge, attitudes, and vaccine status was distributed to all medical students at an Alabama university. Scales were developed to assess composite HPV and HPV knowledge scores and HPV vaccination intentions. Of those age-eligible, 32.1% reported completion of the HPV vaccine series while 15.2% reported partial completion. Knowledge of both HPV and HPV vaccination significantly increased with program year (p < 0.0001 and p = 0.0069, respectively); however, there were knowledge gaps across all years regarding HPV-associated cancers. Attitudes and intentions showed a similar association, with more advanced students demonstrating more positive attitudes toward HPV vaccination (p = 0.0003). There is a need within the current curriculum to include more education and training on HPV, HPV vaccination, and counseling-particularly for students in the first 2 years of their program. Implementation of a classroom module or interactive workshop would likely improve knowledge and attitudes, better preparing students for their future role as potential immunizers.
Identifiants
pubmed: 31502236
doi: 10.1007/s13187-019-01613-3
pii: 10.1007/s13187-019-01613-3
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
168-177Références
Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F (2005) Carcinogenicity of human papillomaviruses. Lancet Oncol 6(4):204
doi: 10.1016/S1470-2045(05)70086-3
HPV and cancer: statistics. https://www.cdc.gov/cancer/hpv/statistics/index.htm . Accessed 8 July 2019
Meites E, Kempe A, Markowitz LE (2016) Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 65(49):1405–1408
doi: 10.15585/mmwr.mm6549a5
Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, Mayrand MH, Ruiz-Sternberg AM, Stapleton JT, Wiley DJ, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Cuzick J, Garland SM, Kjaer SK, Bautista OM, Haupt R, Moeller E, Ritter M, Roberts CC, Shields C, Luxembourg A (2017) Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Lancet 390(10108):2143–2159
doi: 10.1016/S0140-6736(17)31821-4
Van Damme P, Meijer C, Kieninger D, Schuyleman A, Thomas S, Luxembourg A, Baudin M (2016) A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men. Vaccine 34(35):4205–4212
doi: 10.1016/j.vaccine.2016.06.056
Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S (2018) National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2017. MMWR Morb Mortal Wkly Rep 67(33):909–917
doi: 10.15585/mmwr.mm6733a1
Swiecki-Sikora AL, Henry KA, Kepka D (2019) HPV vaccination coverage among US teens across the rural-urban continuum. J Rural Health
Warner EL, Ding Q, Pappas LM, Henry K, Kepka D (2017) White, affluent, educated parents are least likely to choose HPV vaccination for their children: a cross-sectional study of the National Immunization Study - teen. BMC Pediatr 17(1):200
doi: 10.1186/s12887-017-0953-2
Cartmell KB, Young-Pierce J, McGue S, Alberg AJ, Luque JS, Zubizarreta M, Brandt HM (2018) Barriers, facilitators, and potential strategies for increasing HPV vaccination: a statewide assessment to inform action. Papillomavirus Res 5:21–31
doi: 10.1016/j.pvr.2017.11.003
Dilley SE, Peral S, Straughn JM Jr, Scarinci IC (2018) The challenge of HPV vaccination uptake and opportunities for solutions: lessons learned from Alabama. Prev Med 113:124–131
doi: 10.1016/j.ypmed.2018.05.021
Gilkey MB, McRee AL (2016) Provider communication about HPV vaccination: a systematic review. Hum Vaccin Immunother 12(6):1454–1468
doi: 10.1080/21645515.2015.1129090
Gerend MA, Shepherd MA, Lustria ML, Shepherd JE (2016) Predictors of provider recommendation for HPV vaccine among young adult men and women: findings from a cross-sectional survey. Sex Transm Infect 92(2):104–107
doi: 10.1136/sextrans-2015-052088
Smith PJ, Stokley S, Bednarczyk RA, Orenstein WA, Omer SB (2016) HPV vaccination coverage of teen girls: the influence of health care providers. Vaccine 34(13):1604–1610
doi: 10.1016/j.vaccine.2016.01.061
McCusker SM, Macqueen I, Lough G, Macdonald AI, Campbell C, Graham SV (2013) Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland. BMC Public Health 13:264
doi: 10.1186/1471-2458-13-264
Voidazan S, Morariu SH, Tarcea M, Moldovan H, Curticapian I, Dobreanu M (2016) Human papillomavirus (HPV) infection and HPV vaccination: assessing the level of knowledge among students of the University of Medicine and Pharmacy of Tirgu Mures, Romania. Acta dermatovenerol Croatica : ADC 24(3):193–202
Wen Y, Pan XF, Zhao ZM, Chen F, Fu CJ, Li SQ, Zhao Y, Chang H, Xue QP, Yang CX (2014) Knowledge of human papillomavirus (HPV) infection, cervical cancer, and HPV vaccine and its correlates among medical students in Southwest China: a multi-center cross-sectional survey. Asian Pac J Cancer Prev : APJCP 15(14):5773–5779
doi: 10.7314/APJCP.2014.15.14.5773
Shetty S, Prabhu S, Shetty V, Shetty AK (2019) Knowledge, attitudes and factors associated with acceptability of human papillomavirus vaccination among undergraduate medical, dental and nursing students in South India. Hum Vaccines Immunother:1–10
Afonso NM, Kavanagh MJ, Swanberg SM, Schulte JM, Wunderlich T, Lucia VC (2017) Will they lead by example? Assessment of vaccination rates and attitudes to human papilloma virus in millennial medical students. BMC Public Health 17(1):35
doi: 10.1186/s12889-016-3969-x
Berenson AB, Hirth JM, Fuchs EL (2017) US medical students’ willingness to offer the HPV vaccine by vaccination status. Vaccine 35(9):1212–1215
doi: 10.1016/j.vaccine.2017.01.028
Evans L, Matley E, Oberbillig M, Margetts E, Darrow L (2019) HPV knowledge and attitudes among medical and professional students at a Nevada University: a focus on oropharyngeal cancer and mandating the vaccine. Journal of cancer education : the official journal of the American Association for Cancer Education
Wiley R, Shelal Z, Urbauer D, Bernard C, Ramondetta L (2019) Relationship between intent to vaccinate and the education and knowledge of human papillomavirus among medical school faculty and students in Texas. Tex Med 115(1):e1
pubmed: 30601572
Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R, Bruder K, Malo TL, Proveaux T, Zhao X, Halsey N, Giuliano AR (2011) Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 29(47):8634–8641
doi: 10.1016/j.vaccine.2011.09.006
Gilkey MB, Moss JL, Coyne-Beasley T, Hall ME, Shah PD, Brewer NT (2015) Physician communication about adolescent vaccination: how is human papillomavirus vaccine different? Prev Med 77:181–185
doi: 10.1016/j.ypmed.2015.05.024
Hswen Y, Gilkey MB, Rimer BK, Brewer NT (2017) Improving physician recommendations for human papillomavirus vaccination: the role of professional organizations. Sex Transm Dis 44(1):42–47
doi: 10.1097/OLQ.0000000000000543
Lake PW, Kasting ML, Christy SM, Vadaparampil ST (2019) Provider perspectives on multilevel barriers to HPV vaccination. Human vaccines & immunotherapeutics:1–10
State Fact Sheets: Alabama [ https://data.ers.usda.gov/reports.aspx?StateFIPS=01&StateName=Alabama&ID=17854 ]. Accessed 8 July 2019
Schnaith AM, Evans EM, Vogt C, Tinsay AM, Schmidt TE, Tessier KM, Erickson BK (2018) An innovative medical school curriculum to address human papillomavirus vaccine hesitancy. Vaccine 36(26):3830–3835
doi: 10.1016/j.vaccine.2018.05.014
HPV vaccines [ https://www.cancer.org/cancer/cancer-causes/infectious-agents/hpv/hpv-vaccines.html ]. Accessed 10 July 2019